Brief: TScan Therapeutics Inc Says On July 20 Appointed Gavin Macbeath As Interim Principal Financial Officer Of Co, Effective July 21
25/07/2023 11:15
July 25 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS INC- ON JULY 20 APPOINTED GAVIN
MACBEATH,
PH.D., AS INTERIM PRINCIPAL FINANCIAL OFFICER OF CO, EFFECTIVE
JULY 21
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing